About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Boston | 559 Studies

Clinical Trials LymphomaBoston

Lymphoma Clinical Trials in Boston

Find 559 clinical trials for lymphoma near Boston, Massachusetts. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 361-380 of 559 trials

CompletedPRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinThis clinical research study is to investigate the prevention of relapse in patients with diffuse large B cell lymphoma (DLBCL) using enzastaurin daily.NCT00332202·Anchorage, Alaska and 152 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study in Participants With Moderate to Severe PsoriasisThe primary purpose for this study is to help answer the following research questions * The safety of ixekizumab (LY2439821) and any side effects that might be associated with it.NCT01107457·Bakersfield, California and 33 others

CompletedA Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesRATIONALE: A Web site for stem cell transplant health information and support may be effective in helping parents improve their health-related knowledge, skills, and quality of…NCT00782145·Duarte, California and 5 others

CompletedTandem Auto-Allo Transplant for LymphomaRelapse remains a principle cause of treatment failure for patients with aggressive lymphoma after autologous transplantation.NCT01181271·Boston, Massachusetts and 1 other

CompletedTesting the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial SarcomaThis phase II trial studies how well pembrolizumab and interferon gamma-1b work in treating patients with stage IB-IVB mycosis fungoides and Sezary syndrome that has come back…NCT03063632·Palo Alto, California and 6 others

TerminatedVaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00089115·Birmingham, Alabama and 59 others

TerminatedA Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced CancerAG-024322 may work in cancer by stopping cancer cells from multiplying. AG-024322 is and intravenous drug from a new class of drugs call cyclin-dependent kinase (CDK inhibitors).NCT00147485·Boston, Massachusetts and 3 others

RecruitingA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other…NCT01351545·Birmingham, Alabama and 141 others

CompletedSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantRATIONALE: Reducing the amount of drugs used to prevent transplant rejection may help a person's body kill tumor cells.NCT00002657·Mobile, Alabama and 85 others

Active not recruitingBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaThis randomized phase III trial studies how well blinatumomab works compared with standard combination chemotherapy in treating patients with B-cell acute lymphoblastic leukemia…NCT02101853·Birmingham, Alabama and 185 others

CompletedIbrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell TransplantThis phase II trial studies how well ibrutinib works in treating patients after a donor stem cell transplant for lymphoma that is not responding to treatment or has come back.NCT02869633·Birmingham, Alabama and 4 others

CompletedECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell LymphomasThis is a double-blind, randomized, multicenter, phase 3 clinical trial to compare the efficacy and safety of brentuximab vedotin in combination with CHP with the standard-of-care…NCT01777152·Gilbert, Arizona and 143 others

Active not recruitingDose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell LymphomaThis phase II study will evaluate whether a reduction in radiation dose and field size will maintain a high rate of local control while minimizing the risk of acute and late…NCT03681535·Boston, Massachusetts and 11 others

CompletedCyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentRATIONALE: Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer.NCT00066248·Oakland, California and 42 others

RecruitingA Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasThis is a multicenter, first-in-human, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients…NCT05475925·Birmingham, Alabama and 36 others

Active not recruitingA Long-term Extension Study of PCI-32765 (Ibrutinib)The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who…NCT01804686·Duarte, California and 155 others

Active not recruitingDS-3201b in Participants With LymphomasDS-3201b is an experimental drug that is being investigated in clinical research.NCT02732275·Duarte, California and 19 others

CompletedEvaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)A bone marrow transplant, which is a type of stem cell transplant, is a treatment option for people with leukemia or lymphoma.NCT00864227·Duarte, California and 15 others

CompletedMobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsThe purpose of this study is to determine whether the combination of AMD3100 (plerixafor) and granulocyte colony-stimulating factor (G-CSF or generic name filgrastim) is better…NCT00103610·Phoenix, Arizona and 31 others

TerminatedEvent-Related Potential (ERP) Components in Clinical DiagnosisIn this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether…NCT05673759·Boston, Massachusetts

PreviousPage 19 of 28Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia